Log In
Print
BCIQ
Print
Print this Print this
 

Zenpep, pancrelipase (EUR-1008) (formerly Zentase)

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionPorcine-derived pancreatic enzyme product (PEP)
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency (EPI); Treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions such as chronic pancreatitis (CP), gastrointestinal surgery, and pancreatic cancer; Treat exocrine pancreatic insufficiency (EPI) in cystic fibrosis (CF) patients
Regulatory Designation

Partner

Takeda Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$3,438.0M

$2,900.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today